A recent study demonstrated that Photoregulin3, a small molecule targeting NR2E3, partially rescued rhodopsin protein localization in ROs derived from patients with RHO-CNV-associated RP, suggesting a potential therapeutic approach for modifying disease progression [47]. Here, NR2E3 is linked to retinitis pigmentosa 1.